Invus
IN
IN
Invus
About
Key facts
- Portfolio companies
- 13
- Stages
- Late StageSeries BSeries D
- Cheque size
- $3M to $300M
Recent investments
| Date | Company | Round | Amount |
|---|---|---|---|
| 8 Jun 2026 | City Therapeutics | Series B | $100M |
| 2 Jun 2026 | Contraline | Series B | $93M |
| 21 Apr 2026 | Ray Therapeutics | Series B | $125M |
| 7 Jan 2026 | GenSight Biologics | Post IPO | $3M |
| 14 Apr 2021 | CAVA | Undisclosed round | $190M |
| 11 Feb 2020 | CAVA | Undisclosed round | $190M |
| 17 Jul 2019 | CAVA | Undisclosed round | $100M |
| 12 Sept 2018 | CAVA | Undisclosed round | $300M |
Write the first review
Frequently asked
What companies has Invus invested in?
Invus has invested in City Therapeutics, Contraline, Ray Therapeutics, GenSight Biologics, CAVA and 8 more.
SEC filings, insider activity, nonprofit links and pay benchmarks for Invus:
